Skip to content

12 May 2023

EpiEndo Pharmaceuticals attending BIO International Convention in Boston

EpiEndo Pharmaceuticals announces that CEO, Maria Bech, and CFO, Stefán Pétursson, will be attending the BIO International Convention from June 5-8 at the Boston Convention & Exhibition Center in Boston, Massachusetts.

The BIO International Convention is the world's largest biotechnology event, attracting over 14,000 biotech and pharma leaders from around the world. With a focus on driving scientific innovation, the convention provides a useful platform for the EpiEndo team to connect with representatives across partnering and investment and to explore new possibilities.

During the event, EpiEndo will be highlighting its ground-breaking work in developing new treatments for inflammatory disorders. With over 1,500 exhibitors and a range of educational programming, attendees have the chance to connect, network, and learn about the latest advancements in biotech.

If you are interested in connecting with EpiEndo at the BIO International Convention, please get in touch via the partnering system: https://www.bio.org/events/bio-international-convention/one-one-partneringtm